Christopher Shackelton and Adam Gray’s Coliseum Capital filed for its insider purchases in LHC Group, Inc. (LHCG) on November 28th. The Form 4 filing shows Coliseum Capital bought 55 thousand shares in LHCG on November 23 and 25. The average price is $12.86 per share. After that Coliseum Capital takes 2.08 million shares in LHCG, giving an 11% passive stake. Coliseum Capital has made several insider purchases in LHCG after the third quarter. Now its LHCG position is increased by 37% from 1.51 thousand shares at the end of September. Now LHCG is trading at $12.77, and has already dropped by 58% in 2011.

Six other hedge funds were also bullish about LHCG in the second quarter. Chuck Royce’s Royce & Associates took the largest stake among the hedge funds, with 1.92 million shares at that time. Jim Simons’ Renaissance Technologies reported 77 thousand shares, up by 164% from Q1.

Coliseum Capital Management is a privately owned hedge fund. The firm invests in public equity markets. The firm is based in New York City, New York. The firm has a portfolio of $107 million, mainly invested in Services, Financial, and Healthcare sector.

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals in the United States. The company operates two segments: home-based services and facility-based services. The company was founded in 1994 and is based in Lafayette, Louisiana.